Exact Mass: 652.3723

Metocurine

C40H48N2O6+2 (652.3512)

D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant

Gnididilatin

C37H48O10 (652.3247)

Metocurine

C40H48N2O6 (652.3512)

Metocurine is only found in individuals that have used or taken this drug. It is a non-depolarizing muscle relaxant. Patients on chronic anticonvulsant drugs are relatively resistant to metocurine.(PMID: 9915319)Metocurine antagonizes the neurotransmitter action of acetylcholine by binding competitively with cholinergic receptor sites on the motor end-plate. This antagonism is inhibited, and neuromuscular block reversed, by acetylcholinesterase inhibitors such as neostigmine, edrophonium, and pyridostigmine.

Notoginsenoside T1

C36H60O10 (652.4186)

Notoginsenoside T1 is found in tea. Notoginsenoside T1 is a constituent of Panax notoginseng (sanchi) roots. Constituent of Panax notoginseng (sanchi) roots. Notoginsenoside T1 is found in tea.

Uzarigenin 3-[xylosyl-(1->2)-rhamnoside]

C34H52O12 (652.3459)

Uzarigenin 3-[xylosyl-(1->2)-rhamnoside] is found in fruits. Uzarigenin 3-[xylosyl-(1->2)-rhamnoside] is a constituent of Tamarindus indica (tamarind) Constituent of Tamarindus indica (tamarind). Uzarigenin 3-[xylosyl-(1->2)-rhamnoside] is found in fruits.

n-[2(r)-Hydroxy-1(s)-indanyl]-2(r)-phenylmethyl-4(s)-hydroxy-5-[4-[2-benzofuranylmethyl]-2(s)-[tert-butylaminocarbonyl]-piperazinyl]-pentaneamide

C39H48N4O5 (652.3625)

PA(10:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C35H57O9P (652.374)

PA(10:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 4-hydroxy-docosahexaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/10:0)

C35H57O9P (652.374)

PA(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/10:0), in particular, consists of one chain of one 4-hydroxy-docosahexaenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(10:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C35H57O9P (652.374)

PA(10:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 7-hydroxy-docosahexaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/10:0)

C35H57O9P (652.374)

PA(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/10:0), in particular, consists of one chain of one 7-hydroxy-docosahexaenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(10:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C35H57O9P (652.374)

PA(10:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 14-hydroxy-docosahexaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/10:0)

C35H57O9P (652.374)

PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/10:0), in particular, consists of one chain of one 14-hydroxy-docosahexaenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(10:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C35H57O9P (652.374)

PA(10:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 17-hydroxy-docosahexaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/10:0)

C35H57O9P (652.374)

PA(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/10:0), in particular, consists of one chain of one 17-hydroxy-docosahexaenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(10:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C35H57O9P (652.374)

PA(10:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 16,17-epoxy-docosapentaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/10:0)

C35H57O9P (652.374)

PA(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/10:0), in particular, consists of one chain of one 16,17-epoxy-docosapentaenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Beesioside G

C36H60O10 (652.4186)

Rubianoside IV

C36H60O10 (652.4186)

Hydroxymycotrienin B

C36H48N2O9 (652.336)

Bryonioside D

C36H60O10 (652.4186)

Withanoside III

C34H52O12 (652.3459)

Longithorol B

C42H52O6 (652.3764)

Bryonioside E

C36H60O10 (652.4186)

Sutherlandioside A

C36H60O10 (652.4186)

Riisein A

C36H60O10 (652.4186)

Sutherlandioside B

C36H60O10 (652.4186)

Hydroxymycotrienin A

C36H48N2O9 (652.336)

Riisein B

C36H60O10 (652.4186)

Brachyoside B

C36H60O10 (652.4186)

Cherimolacyclopeptide D

C29H48N8O9 (652.3544)

C35H56O11

C35H56O11 (652.3822)

genkwanine C

C37H48O10 (652.3247)

20-hydroxy-11-oxomogroside I A1|20-hydroxy-11-oxomogroside IA1|3beta,20,24,25-tetra-hydroxy-(24R)-cucurbit-5-en-11-one 24-O-beta-D-glucopyranoside

C36H60O10 (652.4186)

dysoxin 3a

C39H56O8 (652.3975)

ohchinolal C

C37H48O10 (652.3247)

cycloastragenol-3-O-glucoside|sieberoside I

C36H60O10 (652.4186)

1-methoxy-7,8-dimethyl-beta-naphthyl-beta-D-glucopuranosyl-4-pimaran-17-oic acid ester

C39H56O8 (652.3975)

2-methyl-1-[2,4,6-trihydroxy-3-(3-methyl-2-butenyl)-5-[6-methyl-1-[2,4,6-trihydroxy-3-(3-methyl-2-butenyl)-5-(2-methyl-1-oxopropyl)phenyl] heptyl]phenyl]-1-butanone

C39H56O8 (652.3975)

(20R,24S)-epoxy-9beta,19-cyclolanostane-3beta,6alpha,16beta,25-tetrol 3-O-beta-D-glucopyranoside

C36H60O10 (652.4186)

C39H56O8

C39H56O8 (652.3975)

petuniasterone C 7,22-dinicotinate

C40H48N2O6 (652.3512)

Kizutasaponin K7A

C36H60O10 (652.4186)

cumingianoside L

C36H60O10 (652.4186)

12??,21-Dihydroxycimigenol 3-O-??-L-arabinopyranoside

C35H56O11 (652.3822)

Myrtucommulone A

C38H52O9 (652.3611)

16-O-beta-D-glucopyranosyl-3,6,16,25-tetrahydroxy-20(R),24(S)-epoxycycloartane|hareftoside D

C36H60O10 (652.4186)

C36H60O10

C36H60O10 (652.4186)

21-O-beta-D-glucopyranosyl-3beta,16beta,21beta,23,28-pentahydroxyolean-12-en|pleurosaponin A

C36H60O10 (652.4186)

effusin A

C40H48N2O6 (652.3512)

(3beta,6beta,12beta,23S,24R,25S)-16,23:23,26-diepoxy-6,12,24,25-tetrahydroxy-9,19-cycloart-3-O-beta-D-xylopyranoside|yunnanterpene F

C35H56O11 (652.3822)

karaviloside XI

C36H60O10 (652.4186)

(20S,24R)-6-O-beta-D-glucopyranosyldammar-3-one-20,24-epoxy-6alpha,12beta,25-triol|pseudoginsenoside RT6

C36H60O10 (652.4186)

paradrymonoside

C35H56O11 (652.3822)

C38H52O9

C38H52O9 (652.3611)

(20S)-3beta,6alpha,12beta20-tetrahydroxydammara-25-ene-24-one 20-O-beta-D-glucopyranoside|floralginsenoside Ta|ginsenoside Rh11

C36H60O10 (652.4186)

genkwanine E

C37H48O10 (652.3247)

Cycloaraloside A

C36H60O10 (652.4186)

16-demethoxymethyllycaconitine|1alpha,6beta,14alpha-trimethoxy-7,8-dihydroxy-18-(2-methyl)succinylanthranoyloxyaconane

C36H48N2O9 (652.336)

(1alpha,3beta,12beta,16beta,24E)-26-O-beta-D-glucopyranoside,Cycloart-24-ene-1,3,12,16,26,-pentol

C36H60O10 (652.4186)

malbrancheoside B

C36H60O10 (652.4186)

huangqiyenin B

C36H60O10 (652.4186)

1beta,2alpha,3beta,19alpha,23-pentahydroxyurs-12-en-28-oic acid-28-O-beta-D-xylopyranoside

C35H56O11 (652.3822)

(20S,22S,23R,24S)-3beta,22,23-trihydroxy-3-O-(beta-D-glucopyranosyl)-32-nor-24-methyllanost-8(9)-en-30-oic acid|ulososide C

C36H60O10 (652.4186)

3-methoxy-6,8-dimethyl-beta-naphthyl-beta-D-glucopyranosyl-6-pimaran-17-oic acid ester|catharanthusopimaranoside A

C39H56O8 (652.3975)

30,30-dichlorocylindrocyclophane A|cylindrocyclophane A2

C36H54Cl2O6 (652.3297)

Pisopowine

C40H48N2O6 (652.3512)

Nostocyclophane D

C36H54Cl2O6 (652.3297)

wikstroelide F

C37H48O10 (652.3247)

cynaphylloside A

C37H48O10 (652.3247)

lipidyl pseudopterane B

C39H56O8 (652.3975)

Thapsigargin

C34H52O12 (652.3459)

Leu Ser Glu Lys Tyr

C30H48N6O10 (652.3432)

Leu Thr Phe Gln Met

C30H48N6O8S (652.3254)

Glu Ile Arg His Val

C28H48N10O8 (652.3656)

Lys Leu Asn His Gln

C28H48N10O8 (652.3656)

C34H52O12_1,5,16-Trihydroxy-26-oxo-6,7:22,26-diepoxyergost-24-en-3-yl hexopyranoside

C34H52O12 (652.3459)

C36H60O10

C36H60O10 (652.4186)

KYVML

C31H52N6O7S (652.3618)

EIRHV

C28H48N10O8 (652.3656)

PI(22:2(13Z,16Z)/0:0)

C31H57O12P (652.3587)

PA(13:0/20:5(5Z,8Z,11Z,14Z,17Z))

C36H61O8P (652.4104)

PA(15:1(9Z)/18:4(6Z,9Z,12Z,15Z))

C36H61O8P (652.4104)

PA(18:4(6Z,9Z,12Z,15Z)/15:1(9Z))

C36H61O8P (652.4104)

PA(20:5(5Z,8Z,11Z,14Z,17Z)/13:0)

C36H61O8P (652.4104)

Uzarigenin 3-[xylosyl-(1->2)-rhamnoside]

C34H52O12 (652.3459)

Notoginsenoside T1

C36H60O10 (652.4186)

1,5,16-Trihydroxy-26-oxo-6,7:22,26-diepoxyergost-24-en-3-yl hexopyranoside

C34H52O12 (652.3459)

LPI 22:2

C31H57O12P (652.3587)

PA 33:5

C36H61O8P (652.4104)

PKODiA-PG

C30H53O13P (652.3224)

Aspacoside E

C34H52O12 (652.3459)

BA-delta5-3beta,7beta-diol 7betaGlcNAc,24G

C33H52N2O11 (652.3571)

Bastaxanthin C2

C38H52O7S (652.3434)

Amyloid β-Protein (16-20) trifluoroacetate salt

C35H52N6O6 (652.3948)

β-Amyloid peptide(16-20) is a amino acid sequences (KLVFF) of Amyloid-β (Abeta). β-Amyloid peptide(16-20) is an effective inhibitor of Abeta fibril formation, with RG-/-GR-NH2 residues added at N- and C-terminal ends to aid solubility)[1].

Alvespimycin hydrochloride

C32H49ClN4O8 (652.3239)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

Metoprolol succinate

C34H56N2O10 (652.3935)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Metoprolol succinate is an orally active, selective β1-adrenoceptor antagonist. Metoprolol succinate shows anti-inflammation, antitumor and anti-angiogenic properties[1][2][3].

N,N-DI-P-TOLYL-N,N-BIS-(4-BUTYLPHENYL)-PHENANTHRENE-9,10-DIAMINE

C48H48N2 (652.3817)

(2S)-4-(1-benzofuran-2-ylmethyl)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butylpiperazine-2-carboxamide

C39H48N4O5 (652.3625)

PA(10:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C35H57O9P (652.374)

PA(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/10:0)

C35H57O9P (652.374)

PA(10:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C35H57O9P (652.374)

PA(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/10:0)

C35H57O9P (652.374)

PA(10:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C35H57O9P (652.374)

PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/10:0)

C35H57O9P (652.374)

PA(10:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C35H57O9P (652.374)

PA(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/10:0)

C35H57O9P (652.374)

PA(10:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C35H57O9P (652.374)

PA(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/10:0)

C35H57O9P (652.374)

2-[[(2R)-3-acetyloxy-2-[7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]-6-oxoheptanoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO12P+ (652.3462)

2-[[(2R)-2-acetyloxy-3-[7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]-6-oxoheptanoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO12P+ (652.3462)

2-[[(2R)-3-acetyloxy-2-[(Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]oxan-3-yl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO12P+ (652.3462)

2-[[(2R)-2-acetyloxy-3-[(Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]oxan-3-yl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO12P+ (652.3462)

Ethidium homodimer tetracation

C41H48N8+4 (652.4002)

1-cyclohexyl-3-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea

C37H56N4O6 (652.42)

1-[(3S,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea

C37H56N4O6 (652.42)

N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-methylbenzenesulfonamide

C35H48N4O6S (652.3294)

2-[[(2R)-2-[(E)-6-carboxy-4-hydroxyhex-5-enoyl]oxy-3-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H59NO11P+ (652.3826)

3,6-diamino-N-[[(8Z)-15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide

C25H44N14O7 (652.3517)

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (13Z,16Z)-docosa-13,16-dienoate

C31H57O12P (652.3587)

Smgdg O-17:2_5:0

C31H56O12S (652.3492)

Smgdg O-16:2_6:0

C31H56O12S (652.3492)

Smgdg O-19:2_3:0

C31H56O12S (652.3492)

Smgdg O-18:2_4:0

C31H56O12S (652.3492)

Smgdg O-20:2_2:0

C31H56O12S (652.3492)

Dgdg O-14:1_2:0

C31H56O14 (652.367)

Dgdg O-13:1_3:0

C31H56O14 (652.367)

[1-acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (Z)-tridec-9-enoate

C30H52O15 (652.3306)

PMeOH 14:1_18:4

C36H61O8P (652.4104)

PMeOH 16:1_16:4

C36H61O8P (652.4104)

PMeOH 12:0_20:5

C36H61O8P (652.4104)

PEtOH 13:1_18:4

C36H61O8P (652.4104)

PEtOH 13:0_18:5

C36H61O8P (652.4104)

PMeOH 14:0_18:5

C36H61O8P (652.4104)

PEtOH 15:1_16:4

C36H61O8P (652.4104)

PMeOH 16:2_16:3

C36H61O8P (652.4104)

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

C36H60O10 (652.4186)

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C36H60O10 (652.4186)

[1-nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C36H60O10 (652.4186)

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C36H60O10 (652.4186)

[1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C36H60O10 (652.4186)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C30H53O13P (652.3224)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C30H53O13P (652.3224)

[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C30H53O13P (652.3224)

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C36H61O8P (652.4104)

[1-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C36H61O8P (652.4104)

[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C36H61O8P (652.4104)

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C36H61O8P (652.4104)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropyl] (Z)-heptadec-9-enoate

C36H61O8P (652.4104)

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-phosphonooxypropyl] (9Z,12Z)-heptadeca-9,12-dienoate

C36H61O8P (652.4104)

(1-pentadecanoyloxy-3-phosphonooxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C36H61O8P (652.4104)

[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C30H53O13P (652.3224)

2-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H59NO8P+ (652.3978)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C36H61O8P (652.4104)

[(2R)-1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

C36H61O8P (652.4104)

[(2R)-1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C36H61O8P (652.4104)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoate

C36H61O8P (652.4104)

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

C36H61O8P (652.4104)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C34H53O10P (652.3376)

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (E)-heptadec-7-enoate

C36H61O8P (652.4104)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoate

C36H61O8P (652.4104)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoate

C36H61O8P (652.4104)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C36H61O8P (652.4104)

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] heptadecanoate

C36H61O8P (652.4104)

[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-phosphonooxypropyl] (8E,11E,14E)-heptadeca-8,11,14-trienoate

C36H61O8P (652.4104)

[1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C36H60O10 (652.4186)

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C36H61O8P (652.4104)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoate

C36H61O8P (652.4104)

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (11E,14E)-heptadeca-11,14-dienoate

C36H61O8P (652.4104)

[1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C36H60O10 (652.4186)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(6E,9E)-dodeca-6,9-dienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C34H53O10P (652.3376)

2-[[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H59NO8P+ (652.3978)

1-(13Z,16Z-docosadienoyl)-glycero-3-phospho-(1-myo-inositol)

C31H57O12P (652.3587)

MGDG O-27:5;O

C36H60O10 (652.4186)

SMGDG O-22:2

C31H56O12S (652.3492)

SQDG 22:1

C31H56O12S (652.3492)

DGMG 16:1

C31H56O14 (652.367)

SQMG 23:1

C32H60O11S (652.3856)

DGGA 25:5;O

C34H52O12 (652.3459)

DGGA 26:4

C35H56O11 (652.3822)

MGGA 27:4

C36H60O10 (652.4186)

PA 18:3/13:4;O2

C34H53O10P (652.3376)

PA 18:4/13:3;O2

C34H53O10P (652.3376)

PA 20:3/12:3;O

C35H57O9P (652.374)

PA 22:6/9:1;O2

C34H53O10P (652.3376)

PA 31:7;O2

C34H53O10P (652.3376)

PA 32:6;O

C35H57O9P (652.374)

PA 11:0_22:5

C36H61O8P (652.4104)

PA 13:0_20:5

C36H61O8P (652.4104)

PA 15:1_18:4

C36H61O8P (652.4104)

PG O-18:0/7:3;O3

C31H57O12P (652.3587)

PG O-18:0/8:2;O2

C32H61O11P (652.3951)

PG O-25:3;O3

C31H57O12P (652.3587)

PG O-26:2;O2

C32H61O11P (652.3951)

PG P-18:0/7:2;O3

C31H57O12P (652.3587)

PG P-18:0/8:1;O2

C32H61O11P (652.3951)

PG 16:0/8:3;O3

C30H53O13P (652.3224)

PG 16:1/8:2;O3

C30H53O13P (652.3224)

PG 16:1/9:1;O2

C31H57O12P (652.3587)

PG 18:0/7:2;O2

C31H57O12P (652.3587)

PG 18:0/8:1;O

C32H61O11P (652.3951)

PG 20:1/5:1;O2

C31H57O12P (652.3587)

PG 22:0/4:1;O

C32H61O11P (652.3951)

PG 25:2;O2

C31H57O12P (652.3587)

PG 26:1;O

C32H61O11P (652.3951)

PI O-18:1/4:1

C31H57O12P (652.3587)

PI O-18:2/4:0

C31H57O12P (652.3587)

PI O-20:2/2:0

C31H57O12P (652.3587)

PI O-21:3;O

C30H53O13P (652.3224)

PI O-22:2

C31H57O12P (652.3587)

PI P-16:1/5:1;O

C30H53O13P (652.3224)

PI P-18:0/4:1

C31H57O12P (652.3587)

PI P-18:0/4:1 or PI O-18:1/4:1

C31H57O12P (652.3587)

PI P-18:1/4:0

C31H57O12P (652.3587)

PI P-18:1/4:0 or PI O-18:2/4:0

C31H57O12P (652.3587)

PI P-20:1/2:0

C31H57O12P (652.3587)

PI P-20:1/2:0 or PI O-20:2/2:0

C31H57O12P (652.3587)

PI P-22:1

C31H57O12P (652.3587)

PI P-22:1 or PI O-22:2

C31H57O12P (652.3587)

PI 17:1/4:1

C30H53O13P (652.3224)

PI 17:2/4:0

C30H53O13P (652.3224)

PI 21:2

C30H53O13P (652.3224)

PEth 30:6;O

C35H57O9P (652.374)

PEth 31:5

C36H61O8P (652.4104)

PM 31:6;O

C35H57O9P (652.374)

PM 32:5

C36H61O8P (652.4104)

ST 28:3;O6;GlcA

C34H52O12 (652.3459)

ST 29:2;O5;GlcA

C35H56O11 (652.3822)

ST 28:4;O7;Hex

C34H52O12 (652.3459)

ST 29:3;O6;Hex

C35H56O11 (652.3822)

n-(1-oxo-1-{[(8z,10z,16z)-3,15,24-trihydroxy-5,22-dimethoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(23),2,6,8,10,16,20(24),21-octaen-13-yl]oxy}propan-2-yl)cyclohexanecarboximidic acid

C37H52N2O8 (652.3723)

{11-ethyl-8,9-dihydroxy-4,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl 2-(3-methyl-2,5-dioxopyrrolidin-1-yl)benzoate

C36H48N2O9 (652.336)

2-[(6s,9s,12s,15s,18s,23as)-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-15-isopropyl-12-methyl-6-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-9-yl]ethanimidic acid

C29H48N8O9 (652.3544)

[(1r,2r,4s,5s,6r,7s,8r,9s,10s,11r,13s,15r,17r)-5,6,7,8,9-pentahydroxy-4,17-dimethyl-13-phenyl-15-(prop-1-en-2-yl)-12,14,18-trioxapentacyclo[11.4.1.0¹,¹⁰.0²,⁶.0¹¹,¹⁵]octadecan-8-yl]methyl (2e,4e,6e)-deca-2,4,6-trienoate

C37H48O10 (652.3247)

(1r,2r,6s,7s,8r,10s,11s,12r,14s,16s,17r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-14-nonyl-5-oxo-16-(prop-1-en-2-yl)-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-17-yl benzoate

C37H48O10 (652.3247)

[(2s,4r,5r,7s,9r,10s,11s,13s,14r,15s,23s,25r)-10,11-dihydroxy-9-(hydroxymethyl)-13,15-dimethyl-12-oxo-4-(prop-1-en-2-yl)-8,24,26,27-tetraoxaheptacyclo[12.10.1.1⁴,²³.1⁵,²³.0¹,⁶.0⁷,⁹.0¹¹,²⁵]heptacosan-2-yl]methyl benzoate

C37H48O10 (652.3247)

(1s,2r,3r,5r,10r,11r,14r,15s)-2,6,6,10-tetramethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-15-[(2s,4r,5s)-4,5,6-trihydroxy-6-methylheptan-2-yl]pentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-one

C36H60O10 (652.4186)

(2r,3r,4s,5s,6r)-2-{[(1s,3r,6s,9s,11s,12s,14s,15r,16r)-6,14-dihydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

6,10-dihydroxy-15-(5-hydroxy-6-methyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-4-one

C36H60O10 (652.4186)

(6r)-6-[(1s)-1-[(1s,2s,4s,5r,7s,9s,10s,11s,14r,15r,18s)-5,9-dihydroxy-10,14-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl]ethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C34H52O12 (652.3459)

(2s)-2-[(3s,3as,5ar,5br,7ar,8s,9s,11ar,11br,13ar,13bs)-9-hydroxy-5a,5b,8,11a,13b-pentamethyl-8-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-hexadecahydrocyclopenta[a]chrysen-3-yl]-2-hydroxypropanoic acid

C36H60O10 (652.4186)

15-(5,6-dihydroxy-6-methylheptan-2-yl)-14-hydroxy-7,7,12,16-tetramethyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-9-one

C36H60O10 (652.4186)

(2r,3r,4s,5s,6r)-2-{[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-6,14-dihydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

(2s,3s,4s,5s,6r)-2-({2-[(2s,4as,8as)-6-[(3s,4ar,5r,6ar,7r,9ar,9bs)-5-hydroxy-3-(2-hydroxypropan-2-yl)-6a,9b-dimethyl-decahydroindeno[5,4-b]pyran-7-yl]-4a-methyl-2,3,4,7,8,8a-hexahydro-1-benzopyran-2-yl]propan-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

{3,4,5-trihydroxy-6-[(3-methoxy-5,7-dimethylnaphthalen-2-yl)oxy]oxan-2-yl}methyl 7-ethyl-1,1,7-trimethyl-decahydro-2h-phenanthrene-4a-carboxylate

C39H56O8 (652.3975)

2-(hydroxymethyl)-6-{[1,6,10-trihydroxy-3a-(hydroxymethyl)-3-isopropyl-5a,8,8,11a,13a-pentamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl]oxy}oxane-3,4,5-triol

C36H60O10 (652.4186)

methyl 8-hydroxy-7-(octadec-9-enoyloxy)-5-oxo-2,9-bis(prop-1-en-2-yl)-4,14-dioxatricyclo[9.2.1.1³,⁶]pentadeca-1(13),6(15),11-triene-12-carboxylate

C39H56O8 (652.3975)

2-({6,14-dihydroxy-15-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-9-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl (1r,2r,4as,6as,6br,8ar,9r,10r,11r,12s,12ar,12bs,14bs)-1,10,11,12-tetrahydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C35H56O11 (652.3822)

2-({1-[4-(3,3-dimethyloxiran-2-yl)-4-hydroxybut-2-en-2-yl]-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-5-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

3,4,5-trihydroxyoxan-2-yl 1,10,11,12-tetrahydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C35H56O11 (652.3822)

(2s)-2-({[(2s)-1-[(2s)-2-({[(2s)-1-[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-4-methylpentanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-methylbutanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)pentanedioic acid

C31H52N6O9 (652.3796)

2-{[14-hydroxy-16-(hydroxymethyl)-15-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

12β,21-dihydroxycimigenol3-o-α-l-arabinopyranoside

C35H56O11 (652.3822)

{"Ingredient_id": "HBIN000742","Ingredient_name": "12\u03b2,21-dihydroxycimigenol3-o-\u03b1-l-arabinopyranoside","Alias": "NA","Ingredient_formula": "C35H56O11","Ingredient_Smile": "CC1(C2CCC3C4(C(C56C(C4(C(CC37C2(C7)CCC1OC8C(C(C(CO8)O)O)O)O)C)C(CC(O5)C(O6)C(C)(C)O)CO)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5789","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

2α, 3β, 23-trihydroxyurs-5, 12-dien-28-oic acid

C35H56O11 (652.3822)

{"Ingredient_id": "HBIN005214","Ingredient_name": "2\u03b1, 3\u03b2, 23-trihydroxyurs-5, 12-dien-28-oic acid","Alias": "NA","Ingredient_formula": "C35H56O11","Ingredient_Smile": "CC1(C2CCC3C4(C(C56C(C4(C(CC37C2(C7)CCC1OC8C(C(C(CO8)O)O)O)O)C)C(CC(O5)C(O6)C(C)(C)O)CO)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42093","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

beesioside g

C36H60O10 (652.4186)

{"Ingredient_id": "HBIN017681","Ingredient_name": "beesioside g","Alias": "NA","Ingredient_formula": "C36H60O10","Ingredient_Smile": "CC1(C2CCC3C4(CC(C(C4(CCC35C2(C5)CCC1OC6C(C(C(C(O6)CO)O)O)O)CO)C7(CCC(O7)C(C)(C)O)C)O)C)C","Ingredient_weight": "652.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2198","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11039570","DrugBank_id": "NA"}

2,6,6,10-tetramethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-15-(4,5,6-trihydroxy-6-methylheptan-2-yl)pentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-one

C36H60O10 (652.4186)

2-[(6-{16,18-dihydroxy-6,10,15,15-tetramethyl-19-oxapentacyclo[10.6.1.0¹,¹⁴.0³,¹¹.0⁶,¹⁰]nonadec-3-en-7-yl}-3-hydroxy-2-methylheptan-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

(2r,3r,4s,5s,6r)-2-{[(1r,3s,3ar,5as,5bs,6s,7ar,9r,10r,11as,13ar,13br)-1,6,10-trihydroxy-3a-(hydroxymethyl)-3-isopropyl-5a,8,8,11a,13a-pentamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

2-[(6s,9s,12s,15s,18s,23as)-6-[(2s)-butan-2-yl]-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-15-isopropyl-12-methyl-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-9-yl]ethanimidic acid

C29H48N8O9 (652.3544)

2-methyl-6-{5,7,11-trihydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hept-1-en-3-one

C36H60O10 (652.4186)

6,7,8,9-tetrahydroxy-8-(hydroxymethyl)-4,17-dimethyl-13-phenyl-15-(prop-1-en-2-yl)-12,14,18-trioxapentacyclo[11.4.1.0¹,¹⁰.0²,⁶.0¹¹,¹⁵]octadecan-5-yl deca-2,4,6-trienoate

C37H48O10 (652.3247)

(3s)-5-{[(1r,3as,5ar,7r,8r,9as,11s,11ar)-8,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-1-[(2r,5r)-1,5,6-trihydroxy-6-methylheptan-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C36H60O10 (652.4186)

4-[(1r)-1-[(9s,10s,14s)-3,14-dihydroxy-7,7,11,11,13,13-hexamethyl-4-(2-methylpropanoyl)-12-oxo-6,15-dioxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadeca-1,3,5(16)-trien-2-yl]-2-methylpropyl]-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione

C38H52O9 (652.3611)

(2r,3s,8s,13r,14s,19r)-8-butyl-19-(4,4-dichlorobutyl)-3,14-dimethyltricyclo[18.2.2.2⁹,¹²]hexacosa-1(22),9,11,20,23,25-hexaene-2,10,13,21,24,26-hexol

C36H54Cl2O6 (652.3297)

2-[(2-{6-[5-hydroxy-3-(2-hydroxypropan-2-yl)-6a,9b-dimethyl-decahydroindeno[5,4-b]pyran-7-yl]-4a-methyl-2,3,4,7,8,8a-hexahydro-1-benzopyran-2-yl}propan-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

(2r,4r,8s,13r,15r,19s)-8,19-dibutyl-4,15-dichloro-2,13-dimethoxytricyclo[18.2.2.2⁹,¹²]hexacosa-1(22),9,11,20,23,25-hexaene-10,21,24,26-tetrol

C36H54Cl2O6 (652.3297)

(6s,6ar,10as,14r)-7,10a,13-trihydroxy-6,14-diisopropyl-2,2,4,4,8,8,10,10-octamethyl-12-(2-methylpropanoyl)-6,6a,7,14-tetrahydro-5,11-dioxapentaphene-1,3,9-trione

C38H52O9 (652.3611)

(2r,3r,4s,5s,6r)-2-{[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-9,14-dihydroxy-15-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

(2s,3r,4s,5s,6r)-2-{[(3s,6r)-6-[(1s,6r,7r,10s,11r,12s,14s,16r,18s)-16,18-dihydroxy-6,10,15,15-tetramethyl-19-oxapentacyclo[10.6.1.0¹,¹⁴.0³,¹¹.0⁶,¹⁰]nonadec-3-en-7-yl]-3-hydroxy-2-methylheptan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

2-[1,4,7,10,13,16-hexahydroxy-18-(1-hydroxyethyl)-15-isopropyl-12-methyl-6-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-9-yl]ethanimidic acid

C29H48N8O9 (652.3544)

2-{[2,16-dihydroxy-19-(hydroxymethyl)-22-(2-hydroxypropan-2-yl)-3,8,8,17-tetramethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}oxane-3,4,5-triol

C35H56O11 (652.3822)

(1r,3as,3bs,7s,9ar,9br,11ar)-1-[(2s)-3,5-dihydroxy-6-methyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-7-hydroxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

C36H60O10 (652.4186)

(2r)-1-{6-[(1r)-1-[5,7-dihydroxy-2,2-dimethyl-8-(2-methylpropanoyl)-3,4-dihydro-1-benzopyran-6-yl]-6-methylheptyl]-5,7-dihydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-8-yl}-2-methylbutan-1-one

C39H56O8 (652.3975)

(2r,3r,4s,5r,6r)-2-{[(1s,3r,6s,8r,11s,12s,14s,15r,16s)-14-hydroxy-16-(hydroxymethyl)-15-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

[(1r,2r,4r,5r,6s,7s,9r,10s,11s,13s,14r,15r,23s,25r)-10,11-dihydroxy-9-(hydroxymethyl)-13,15-dimethyl-12-oxo-4-(prop-1-en-2-yl)-8,24,26,27-tetraoxaheptacyclo[12.10.1.1⁴,²³.1⁵,²³.0¹,⁶.0⁷,⁹.0¹¹,²⁵]heptacosan-2-yl]methyl benzoate

C37H48O10 (652.3247)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-(acetyloxy)-15-[(2s,3r,5s)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-hydroxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl benzoate

C39H56O8 (652.3975)

(6s)-6-[(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-5,7,11-trihydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hept-1-en-3-one

C36H60O10 (652.4186)

1-(6-{1-[5,7-dihydroxy-2,2-dimethyl-8-(2-methylpropanoyl)-3,4-dihydro-1-benzopyran-6-yl]-6-methylheptyl}-5,7-dihydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-8-yl)-2-methylbutan-1-one

C39H56O8 (652.3975)

[(1s,2r,3r,4s,5s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-8,9-dihydroxy-4,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-[(3s)-3-methyl-2,5-dioxopyrrolidin-1-yl]benzoate

C36H48N2O9 (652.336)

(1r,3as,3bs,7s,9ar,9br,11ar)-1-[(2s,3r,5r)-3,5-dihydroxy-6-methyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-7-hydroxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

C36H60O10 (652.4186)

8-butyl-19-(4,4-dichlorobutyl)-3,14-dimethyltricyclo[18.2.2.2⁹,¹²]hexacosa-1(22),9,11,20,23,25-hexaene-2,10,13,21,24,26-hexol

C36H54Cl2O6 (652.3297)

2-methyl-1-(2,4,6-trihydroxy-3-{6-methyl-1-[2,4,6-trihydroxy-3-(3-methylbut-2-en-1-yl)-5-(2-methylpropanoyl)phenyl]heptyl}-5-(3-methylbut-2-en-1-yl)phenyl)butan-1-one

C39H56O8 (652.3975)

6-[1-(5,9-dihydroxy-10,14-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl)ethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C34H52O12 (652.3459)

4-[(1s)-1-{2,4-dihydroxy-5-[(1r)-1-(2-hydroxy-3,3,5,5-tetramethyl-4,6-dioxocyclohex-1-en-1-yl)-2-methylpropyl]-3-(2-methylpropanoyl)phenyl}-2-methylpropyl]-5-hydroxy-2,2,6,6-tetramethylcyclohex-4-ene-1,3-dione

C38H52O9 (652.3611)

(2r,3r,4s,5s,6r)-2-{[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-9,14-dihydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

5-{[8,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-1-(1,5,6-trihydroxy-6-methylheptan-2-yl)-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C36H60O10 (652.4186)

(1s,2r,3r,5r,10r,11r,14s,15r)-2,6,6,10-tetramethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-15-[(2r,4r,5s)-4,5,6-trihydroxy-6-methylheptan-2-yl]pentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-one

C36H60O10 (652.4186)

2-(hydroxymethyl)-6-{[5,9,17,17-tetramethyl-8-(4,5,6-trihydroxy-6-methylheptan-2-yl)-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-16-yl]oxy}oxane-3,4,5-triol

C36H60O10 (652.4186)

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-1-[(2e,4s)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-hydroxybut-2-en-2-yl]-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

(1r,2s,5s,7s,9s,11s,12s,15r,16r)-15-[(2r,5r)-5,6-dihydroxy-6-methylheptan-2-yl]-1,6,6,12,16-pentamethyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-18-one

C36H60O10 (652.4186)

5-{[(1r,3as,5ar,7r,8r,9as,11s,11ar)-7,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-1-[(2r,5r)-1,5,6-trihydroxy-6-methylheptan-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C36H60O10 (652.4186)

(2r,3s,4r,5r,6r)-2-(hydroxymethyl)-6-{[(1r,4s,5s,8r,9r,12s,13s,16s)-5,9,17,17-tetramethyl-8-[(2r,4s,5s)-4,5,6-trihydroxy-6-methylheptan-2-yl]-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-16-yl]oxy}oxane-3,4,5-triol

C36H60O10 (652.4186)

(2r,3s)-3-[(1r,3as,3bs,4r,9ar,9bs,11ar)-9a,11a-dimethyl-7-oxo-4-(pyridine-3-carbonyloxy)-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2s)-2,3,3-trimethyloxiran-2-yl]butan-2-yl pyridine-3-carboxylate

C40H48N2O6 (652.3512)

(3s,3ar,4s,6s,6ar,7s,8s,9bs)-6-(acetyloxy)-4-(butanoyloxy)-3,3a-dihydroxy-8-{[(1s,2z)-1-hydroxy-2-methylbut-2-en-1-yl]oxy}-3,6,9-trimethyl-2-oxo-4h,5h,6ah,7h,8h,9bh-azuleno[4,5-b]furan-7-yl octanoate

C34H52O12 (652.3459)

(1s,3s,6r,8s,10s,11s,12s,15r,16r)-6,10-dihydroxy-15-[(2r,5s)-5-hydroxy-6-methyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-4-one

C36H60O10 (652.4186)

(5e,21z,31e)-12,25,28,30,35-pentahydroxy-6,22,32-trimethyl-9-(prop-1-en-2-yl)pentacyclo[16.15.1.1¹⁰,¹⁴.0²,¹⁶.0²⁴,²⁹]pentatriaconta-5,10(35),11,13,18(34),21,24,26,28,31-decaene-2-carbaldehyde

C42H52O6 (652.3764)

methyl (2r,3r,7r,8r,9r)-8-hydroxy-7-[(9z)-octadec-9-enoyloxy]-5-oxo-2,9-bis(prop-1-en-2-yl)-4,14-dioxatricyclo[9.2.1.1³,⁶]pentadeca-1(13),6(15),11-triene-12-carboxylate

C39H56O8 (652.3975)

(6r)-6-[(1r,3as,3bs,5r,5ar,7s,9ar,9bs,11ar)-7-{[(2s,3s,4r,5r)-4-(acetyloxy)-3,5-dihydroxyoxan-2-yl]oxy}-5,5a-dihydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]-2-methylheptyl acetate

C36H60O10 (652.4186)

n-[(2r)-1-oxo-1-{[(6z,8z,10z,16z)-3,15,24-trihydroxy-5-methoxy-14,16-dimethyl-21,22-dioxo-2-azabicyclo[18.3.1]tetracosa-1(23),2,6,8,10,16,20(24)-heptaen-13-yl]oxy}propan-2-yl]cyclohexanecarboximidic acid

C36H48N2O9 (652.336)

6-(acetyloxy)-4-(butanoyloxy)-3,3a-dihydroxy-8-[(1-hydroxy-2-methylbut-2-en-1-yl)oxy]-3,6,9-trimethyl-2-oxo-4h,5h,6ah,7h,8h,9bh-azuleno[4,5-b]furan-7-yl octanoate

C34H52O12 (652.3459)

2,17,31,33,35-pentahydroxy-4,11,27-trimethyl-14-(prop-1-en-2-yl)pentacyclo[27.2.2.1⁶,²³.1¹⁵,¹⁹.0⁷,²¹]pentatriaconta-1(31),3,10,15(35),16,18,23(34),26,29,32-decaene-7-carbaldehyde

C42H52O6 (652.3764)

(6r)-6-[(1r,3as,3bs,5r,5ar,7s,9ar,9bs,11ar)-7-{[(2s,3s,4s,5r)-5-(acetyloxy)-3,4-dihydroxyoxan-2-yl]oxy}-5,5a-dihydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]-2-methylheptyl acetate

C36H60O10 (652.4186)

(2s,3e,6r,7r,10e,14r,21s,26z)-2,17,30,32,35-pentahydroxy-4,11,27-trimethyl-14-(prop-1-en-2-yl)pentacyclo[27.2.2.1⁶,²³.1¹⁵,¹⁹.0⁷,²¹]pentatriaconta-1(31),3,10,15(35),16,18,23(34),26,29,32-decaene-7-carbaldehyde

C42H52O6 (652.3764)

(2r,3r,4s,5s,6r)-2-{[(1s,3r,6s,8s,9s,11r,12s,14s,15r,16r)-9,14-dihydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

n-(1-oxo-1-{[(8e,10e,16z)-3,13,24-trihydroxy-5-methoxy-14,16-dimethyl-21,22-dioxo-2-azabicyclo[18.3.1]tetracosa-1(23),2,6,8,10,16,20(24)-heptaen-15-yl]oxy}propan-2-yl)cyclohexanecarboximidic acid

C36H48N2O9 (652.336)

(2r,3r,4s,5s,6r)-2-{[(1s,3r,6s,8r,11s,12s,14s,15r,16s)-14-hydroxy-16-(hydroxymethyl)-15-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

(2r,3r,4s,5s,6r)-2-{[(1r,3s,3ar,5as,5bs,6s,7as,9r,10r,11as,13ar,13br)-1,6,10-trihydroxy-3a-(hydroxymethyl)-3-isopropyl-5a,8,8,11a,13a-pentamethyl-1h,2h,3h,4h,5h,5bh,6h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

(1s,3r,6s,8r,11s,12s,14s,15r,16r)-15-[(2r,5s)-5,6-dihydroxy-6-methylheptan-2-yl]-14-hydroxy-7,7,12,16-tetramethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-9-one

C36H60O10 (652.4186)

(1r,2s,5s,7s,9s,11s,12s,15r,16r)-15-[(2r,5r)-5,6-dihydroxy-6-methylheptan-2-yl]-1,6,6,12,16-pentamethyl-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-18-one

C36H60O10 (652.4186)

(1r,3as,9as,11as)-2,8-dihydroxy-1-[(2r)-2-hydroxy-6-methyl-3-oxoheptan-2-yl]-3a,6,6,11a-tetramethyl-7-{[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,9bh,11h-cyclopenta[a]phenanthren-10-one

C35H56O11 (652.3822)

2-({9,14-dihydroxy-15-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

2-({[1-(2-{[(1-{2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-4-methylpentanoyl}pyrrolidin-2-yl)(hydroxy)methylidene]amino}-3-methylbutanoyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)pentanedioic acid

C31H52N6O9 (652.3796)

(1r,2r,6s,8r,11r,12s,13r,16r,17r,19s,20r)-19-(acetyloxy)-8-(furan-3-yl)-1,9,11,16-tetramethyl-17-[(2-methylpropanoyl)oxy]-4-oxo-5,14-dioxapentacyclo[11.6.1.0²,¹¹.0⁶,¹⁰.0¹⁶,²⁰]icos-9-en-12-yl (2e)-2-methylbut-2-enoate

C37H48O10 (652.3247)

2-({9,13-dihydroxy-14-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

3-[9a,11a-dimethyl-7-oxo-4-(pyridine-3-carbonyloxy)-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-(2,3,3-trimethyloxiran-2-yl)butan-2-yl pyridine-3-carboxylate

C40H48N2O6 (652.3512)

8,19-dibutyl-4,15-dichloro-2,13-dimethoxytricyclo[18.2.2.2⁹,¹²]hexacosa-1(22),9,11,20,23,25-hexaene-10,21,24,26-tetrol

C36H54Cl2O6 (652.3297)

19-(acetyloxy)-8-(furan-3-yl)-1,9,11,16-tetramethyl-17-[(2-methylpropanoyl)oxy]-4-oxo-5,14-dioxapentacyclo[11.6.1.0²,¹¹.0⁶,¹⁰.0¹⁶,²⁰]icos-9-en-12-yl 2-methylbut-2-enoate

C37H48O10 (652.3247)

[(1r,2s,4r,5r,6s,7s,9r,10s,11s,13s,14s,15r,25r)-10,11-dihydroxy-9-(hydroxymethyl)-13,15-dimethyl-12-oxo-4-(prop-1-en-2-yl)-8,24,26,27-tetraoxaheptacyclo[12.10.1.1⁴,²³.1⁵,²³.0¹,⁶.0⁷,⁹.0¹¹,²⁵]heptacosan-2-yl]methyl benzoate

C37H48O10 (652.3247)

[10,11-dihydroxy-9-(hydroxymethyl)-13,15-dimethyl-12-oxo-4-(prop-1-en-2-yl)-8,24,26,27-tetraoxaheptacyclo[12.10.1.1⁴,²³.1⁵,²³.0¹,⁶.0⁷,⁹.0¹¹,²⁵]heptacosan-2-yl]methyl benzoate

C37H48O10 (652.3247)

3-(acetyloxy)-15-[5-(1,2-dihydroxy-2-methylpropyl)-2-hydroxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl benzoate

C39H56O8 (652.3975)

5-{[7,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-1-(1,5,6-trihydroxy-6-methylheptan-2-yl)-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C36H60O10 (652.4186)

(2r)-2-methyl-1-{2,4,6-trihydroxy-3-[(1r)-6-methyl-1-[2,4,6-trihydroxy-3-(3-methylbut-2-en-1-yl)-5-(2-methylpropanoyl)phenyl]heptyl]-5-(3-methylbut-2-en-1-yl)phenyl}butan-1-one

C39H56O8 (652.3975)

(1r,2r,4s,5s,6s,7s,8r,9s,10s,11r,13s,15r,17r)-6,7,8,9-tetrahydroxy-8-(hydroxymethyl)-4,17-dimethyl-13-phenyl-15-(prop-1-en-2-yl)-12,14,18-trioxapentacyclo[11.4.1.0¹,¹⁰.0²,⁶.0¹¹,¹⁵]octadecan-5-yl (2e,4e,6e)-deca-2,4,6-trienoate

C37H48O10 (652.3247)

(2r,3r,4s,5s,6r)-2-{[(1s,3r,6s,8r,9s,11r,12s,13r,14r,16r)-9,13-dihydroxy-14-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

(2s,3r,4r,5r,6r)-2-{[(2r,3r,4r,6r)-6-{[(2s,3s,6s,8s,11r,14r,17r,18s,19s)-19-hydroxy-3,13,18-trimethyl-12,20-dioxahexacyclo[11.6.1.0²,¹¹.0³,⁸.0¹¹,¹⁷.0¹⁴,¹⁸]icosan-6-yl]oxy}-4-methoxy-2-methyloxan-3-yl]oxy}-4-methoxy-6-methyloxane-3,5-diol

C35H56O11 (652.3822)

(2r,3r,4s,5r,6r)-2-{[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-6,14-dihydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O10 (652.4186)

(2s,3e,6s,7s,10e,14r,21s,26z)-2,17,31,33,35-pentahydroxy-4,11,27-trimethyl-14-(prop-1-en-2-yl)pentacyclo[27.2.2.1⁶,²³.1¹⁵,¹⁹.0⁷,²¹]pentatriaconta-1(31),3,10,15(35),16,18,23(34),26,29,32-decaene-7-carbaldehyde

C42H52O6 (652.3764)

(2s,3r,4s,5s)-2-{[(1s,2r,3s,4r,7r,9s,12r,14r,16r,17r,18r,19r,21r,22s)-2,16-dihydroxy-19-(hydroxymethyl)-22-(2-hydroxypropan-2-yl)-3,8,8,17-tetramethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}oxane-3,4,5-triol

C35H56O11 (652.3822)

[5,6,7,8,9-pentahydroxy-4,17-dimethyl-13-phenyl-15-(prop-1-en-2-yl)-12,14,18-trioxapentacyclo[11.4.1.0¹,¹⁰.0²,⁶.0¹¹,¹⁵]octadecan-8-yl]methyl deca-2,4,6-trienoate

C37H48O10 (652.3247)

(2s,3e,6r,7s,10e,14s,21s,26z)-2,17,30,32,35-pentahydroxy-4,11,27-trimethyl-14-(prop-1-en-2-yl)pentacyclo[27.2.2.1⁶,²³.1¹⁵,¹⁹.0⁷,²¹]pentatriaconta-1(31),3,10,15(35),16,18,23(34),26,29,32-decaene-7-carbaldehyde

C42H52O6 (652.3764)

(1r,6s,7s,8r,10s,11s,12r,14s,16s,17r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-14-nonyl-5-oxo-16-(prop-1-en-2-yl)-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-17-yl benzoate

C37H48O10 (652.3247)

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(3-methoxy-5,7-dimethylnaphthalen-2-yl)oxy]oxan-2-yl]methyl (4as,4bs,7s,8as,10as)-7-ethyl-1,1,7-trimethyl-decahydro-2h-phenanthrene-4a-carboxylate

C39H56O8 (652.3975)